JPS57116017A - Antithrombogenetic or anticoagulative agent - Google Patents

Antithrombogenetic or anticoagulative agent

Info

Publication number
JPS57116017A
JPS57116017A JP56002724A JP272481A JPS57116017A JP S57116017 A JPS57116017 A JP S57116017A JP 56002724 A JP56002724 A JP 56002724A JP 272481 A JP272481 A JP 272481A JP S57116017 A JPS57116017 A JP S57116017A
Authority
JP
Japan
Prior art keywords
panax
ginseng
antithrombogenetic
active component
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56002724A
Other languages
Japanese (ja)
Inventor
Fumio Kono
Hikoichi Oura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YAMAKAWA BOEKI KK
YAMAKAWA BOUEKI KK
Original Assignee
YAMAKAWA BOEKI KK
YAMAKAWA BOUEKI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YAMAKAWA BOEKI KK, YAMAKAWA BOUEKI KK filed Critical YAMAKAWA BOEKI KK
Priority to JP56002724A priority Critical patent/JPS57116017A/en
Publication of JPS57116017A publication Critical patent/JPS57116017A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

PURPOSE: To provide an orally administrable antithrombogenetic or anticoagulative agent containing ginseng saponin as an active component, useful for the prevention and remedy of thrombotic cerebromalacia, thrombocytopenic purpura, etc., and free from side effects.
CONSTITUTION: The agent contains ginseng saponin extracted from Panax ginseng C.A.MEYER, Panax japonicus C.A.MEYER, Panax quinchiforium LINNE, and/or Panax pseudo-ginseng WALL., as an active component. It may contain heparin or urokinase as a subsidiary active component. Ginseng saponin has stronger antithrombin activity than heparin and can be used not only as an antithrombogenetic agent but also for the prevention of blood coagulation in the extracorporeal circulation (artificial kidney, artificial heart and lung) and during stronge. Since ginseng saponin has no hemolytic activity in contrast with the other saponins, it can be used as an injection. It is also effective by oral administration in contrast with heparin, exhibits no side effect, and is suitable for the long-term administration.
COPYRIGHT: (C)1982,JPO&Japio
JP56002724A 1981-01-13 1981-01-13 Antithrombogenetic or anticoagulative agent Pending JPS57116017A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56002724A JPS57116017A (en) 1981-01-13 1981-01-13 Antithrombogenetic or anticoagulative agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56002724A JPS57116017A (en) 1981-01-13 1981-01-13 Antithrombogenetic or anticoagulative agent

Publications (1)

Publication Number Publication Date
JPS57116017A true JPS57116017A (en) 1982-07-19

Family

ID=11537252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56002724A Pending JPS57116017A (en) 1981-01-13 1981-01-13 Antithrombogenetic or anticoagulative agent

Country Status (1)

Country Link
JP (1) JPS57116017A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123121A (en) * 1981-01-26 1982-07-31 Sunstar Inc Thrombolytic agent
JPH01207243A (en) * 1988-02-12 1989-08-21 Tsumura & Co Inhibitor of blood platelet aggregation
US6255296B1 (en) * 1994-01-11 2001-07-03 Endomatrix, Inc. Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease
CN102920836A (en) * 2012-11-28 2013-02-13 徐昌万 Traditional Chinese medicine composite for treating immune thrombocytopenic purpura
CN107496617A (en) * 2017-09-30 2017-12-22 张雷 A kind of Chinese medicine composition for being used to treat anaphylactoid purpura

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123121A (en) * 1981-01-26 1982-07-31 Sunstar Inc Thrombolytic agent
JPH01207243A (en) * 1988-02-12 1989-08-21 Tsumura & Co Inhibitor of blood platelet aggregation
US6255296B1 (en) * 1994-01-11 2001-07-03 Endomatrix, Inc. Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease
CN102920836A (en) * 2012-11-28 2013-02-13 徐昌万 Traditional Chinese medicine composite for treating immune thrombocytopenic purpura
CN107496617A (en) * 2017-09-30 2017-12-22 张雷 A kind of Chinese medicine composition for being used to treat anaphylactoid purpura

Similar Documents

Publication Publication Date Title
Harenberg Review of pharmacodynamics, pharmacokinetics, and therapeutic properites of sulodexide
ES8201596A1 (en) their preparation and use as medicines.
JPS57116017A (en) Antithrombogenetic or anticoagulative agent
JPS5795914A (en) Antithrombin-like drug
JPS57134419A (en) Stable anticoagulant of blood
NO954175L (en) Use of vWF-containing concentrates as combination therapy in antithrombotic and fibrinolytic therapy
JPS5692216A (en) Peripheral circulation improver containing crude drug
JPS57163315A (en) Preventing agent and remedy for thrombosis
JPS56138110A (en) Suppository containing citric acid or salt thereof
JPS55122724A (en) Antidiabetic agent
JPS574922A (en) Agent for lowering ammonia in blood
JPS57128635A (en) Pharmaceutical preparation of gamma-globulin for venoclysis
Porush et al. Urinary concentrating operation in caval dogs
IKUSHIMA et al. INDICATION OF OPEN TREATMENT FOR TUBERCULOUS EMPYEMA THORACIS
JPS55122721A (en) Antidiabetic agent
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
JPS56125305A (en) Creamy or milky lotion cosmetic
Jing Dynamic changes of platelet aggregation and serum fibrin derived products after smoke inhalation injury in rabbits
JPS5779879A (en) Safety cabinet
Sorsby Infections of the eye
JPS5738724A (en) Blood sugar level lowering agent
Ames Oxazepam and carbamazepine for alcohol withdrawal
Abildgaard et al. Does the “post-heparin effect” explain the discrepancy between antithrombotic and anticoagulant effects of LMW and standard heparins?
JPS57145817A (en) Remedy for peptic ulcer
Hafner et al. Use of thrombin-antithrombin III complex in controlling low molecular weight heparin treatment during acute dialyses